Theresa Neil: The Menstrual Health Market Map is Ready
Theresa Neil, Founder and CEO Femovate, shared a post on LinkedIn:
“The Menstrual Health Market Map is ready
Over 100 million women track their cycles on apps. They log menstrual patterns, pain levels, mood shifts, sleep, energy, and every symptom that gets brushed off in the exam room.
And still, most of that data hasn’t made its way into clinical care. It sits in silos. It doesn’t trigger screening. It doesn’t support early diagnosis. A woman can walk in with three years of documented pain and her doctor will scroll a few screenshots and say, “Periods can be rough.”
We also have real economic costs. In the Netherlands alone, menstrual symptoms cost an estimated 1.9 billion euros each year. Most of that is presenteeism, not absence. Women keep working through pain because they’re told it’s normal.
But…Cycle tracking has hit a ceiling. The category is saturated. The opportunity has shifted. It’s not in another period tracker. It’s in the infrastructure that connects awareness to actual care.
How do we turn years of symptom tracking into early diagnosis? How do we connect tracking to screening and evidence based treatment? How do we move from self knowledge to real care pathways?
That is where the next wave of innovation will happen.
Explore the full report.”


Get the latest from Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery